BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
SMS Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
532815
ISIN Demat
INE812G01025
Book Value (Rs)
85.9335567
NSE Symbol
SMSPHARMA
Divident Yield %
0.11
Market Cap
(Rs In Cr.)
3,345
P/E (TTM)
36.94
EPS (TTM)
9.67
Face Value
(Rs)
1
Back
SMS Pharmaceuticals consolidated net profit rises 60.97% in the March 2026 quarter
22-May-26   Hrs IST

Net profit of SMS Pharmaceuticals rose 60.97% to Rs 32.71 crore in the quarter ended March 2026 as against Rs 20.32 crore during the previous quarter ended March 2025. Sales declined 4.13% to Rs 237.95 crore in the quarter ended March 2026 as against Rs 248.20 crore during the previous quarter ended March 2025.

For the full year,net profit rose 47.51% to Rs 101.99 crore in the year ended March 2026 as against Rs 69.14 crore during the previous year ended March 2025. Sales rose 13.30% to Rs 886.87 crore in the year ended March 2026 as against Rs 782.75 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales237.95248.20 -4 886.87782.75 13
OPM %16.7716.44 -19.3117.76 -
PBDT37.2037.16 0 156.56126.67 24
PBT27.0728.52 -5 116.6492.34 26
NP32.7120.32 61 101.9969.14 48

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)